JP2020525502A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020525502A5 JP2020525502A5 JP2019572458A JP2019572458A JP2020525502A5 JP 2020525502 A5 JP2020525502 A5 JP 2020525502A5 JP 2019572458 A JP2019572458 A JP 2019572458A JP 2019572458 A JP2019572458 A JP 2019572458A JP 2020525502 A5 JP2020525502 A5 JP 2020525502A5
- Authority
- JP
- Japan
- Prior art keywords
- solvate
- hydrate
- group
- conjugate
- chemical formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 C*(C)OC(N)(N)NC Chemical compound C*(C)OC(N)(N)NC 0.000 description 2
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15/641,251 US20190125884A1 (en) | 2017-07-04 | 2017-07-04 | Compounds and methods for trans-membrane delivery of molecules |
| US15/641,251 | 2017-07-04 | ||
| US201715662665A | 2017-07-28 | 2017-07-28 | |
| US15/662,665 | 2017-07-28 | ||
| US201715679192A | 2017-08-17 | 2017-08-17 | |
| US15/679,192 | 2017-08-17 | ||
| US15/691,821 | 2017-08-31 | ||
| US15/691,821 US10195286B2 (en) | 2017-07-04 | 2017-08-31 | Compounds and methods for trans-membrane delivery of molecules |
| PCT/IL2018/050714 WO2019008574A1 (en) | 2017-07-04 | 2018-07-02 | COMPOUNDS AND METHODS FOR TRANSMEMBRANE ADMINISTRATION OF MOLECULES |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020525502A JP2020525502A (ja) | 2020-08-27 |
| JP2020525502A5 true JP2020525502A5 (https=) | 2021-08-12 |
| JP7191869B2 JP7191869B2 (ja) | 2022-12-19 |
Family
ID=64903980
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019572458A Active JP7191869B2 (ja) | 2017-07-04 | 2018-07-02 | 分子を経膜送達するための化合物及び方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US10195286B2 (https=) |
| EP (1) | EP3648773A4 (https=) |
| JP (1) | JP7191869B2 (https=) |
| CN (1) | CN111246855A (https=) |
| AU (1) | AU2018295899B2 (https=) |
| CA (1) | CA3068165A1 (https=) |
| IL (1) | IL271788B1 (https=) |
| WO (1) | WO2019008574A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL267919B2 (en) | 2017-01-09 | 2024-03-01 | Aposense Ltd | Compounds and methods for transmembrane transfer of molecules |
| US11236334B2 (en) | 2017-08-22 | 2022-02-01 | National University Corporation Nagoya University | Modified polynucleotide |
| IL275773B2 (en) * | 2018-01-01 | 2025-07-01 | Aposense Ltd | Compounds and methods for trans-membrane delivery of molecules |
| WO2020044349A1 (en) * | 2018-08-30 | 2020-03-05 | Aposense Ltd. | Compounds, cojugates and compositions for use in the methods for trans-membrane delivery of molecules |
| US12606863B2 (en) | 2021-05-13 | 2026-04-21 | Promega Corporation | Bioluminescent detection of DNA synthesis |
| JPWO2023022055A1 (https=) * | 2021-08-17 | 2023-02-23 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1622572B1 (en) | 2003-04-30 | 2017-12-20 | Sirna Therapeutics, Inc. | Conjugates and compositions for cellular delivery |
| WO2009082607A2 (en) | 2007-12-04 | 2009-07-02 | Alnylam Pharmaceuticals, Inc. | Targeting lipids |
| WO2012018729A1 (en) | 2010-08-03 | 2012-02-09 | Berry And Associates, Inc. | Phosphoramidite derivatives of folic acid |
| US9993563B2 (en) | 2014-03-28 | 2018-06-12 | Aposense Ltd. | Compounds and methods for trans-membrane delivery of molecules |
| CA2944141C (en) | 2014-03-28 | 2023-03-28 | Aposense Ltd. | Compounds and methods for trans-membrane delivery of molecules |
| IL267919B2 (en) * | 2017-01-09 | 2024-03-01 | Aposense Ltd | Compounds and methods for transmembrane transfer of molecules |
-
2017
- 2017-08-31 US US15/691,821 patent/US10195286B2/en active Active
-
2018
- 2018-07-02 CA CA3068165A patent/CA3068165A1/en active Pending
- 2018-07-02 CN CN201880057472.7A patent/CN111246855A/zh active Pending
- 2018-07-02 EP EP18828375.8A patent/EP3648773A4/en active Pending
- 2018-07-02 JP JP2019572458A patent/JP7191869B2/ja active Active
- 2018-07-02 AU AU2018295899A patent/AU2018295899B2/en active Active
- 2018-07-02 WO PCT/IL2018/050714 patent/WO2019008574A1/en not_active Ceased
-
2019
- 2019-12-31 IL IL271788A patent/IL271788B1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020525502A5 (https=) | ||
| AU2021203840B2 (en) | N4-hydroxycytidine and derivatives and anti-viral uses related thereto | |
| AU710074B2 (en) | Novel method of preparation of known and novel 2'-modified nucleosides by intramolecular nucleophilic displacement | |
| US20220370635A1 (en) | Compositions containing nucleic acid nanoparticles with modular functionality | |
| JP2018509143A5 (https=) | ||
| JP2020022483A5 (https=) | ||
| JP2020514299A5 (https=) | ||
| RU2006109491A (ru) | Новые трициклические нуклеозиды или нуклеотиды в качестве терапевтических средств | |
| AU2017326372B2 (en) | Modified oligonucleotides and methods of use | |
| JP2020512843A5 (https=) | ||
| WO2003062256A1 (en) | 2'-beta-modified-6-substituted adenosine analogs and their use as antiviral agents | |
| JP2018530560A5 (https=) | ||
| JP2018538302A5 (https=) | ||
| HRP20191471T1 (hr) | Molekule nukleinske kiseline modificirane saharidom | |
| KR950032265A (ko) | 폴리아미드-올리고뉴클레오타이드 유도체, 이의 제조방법 및 용도 | |
| JP2018525015A5 (https=) | ||
| WO2014169216A2 (en) | TEMPLATE-DIRECTED γPNA SYNTHESIS AND γPNA TARGETING COMPOUNDS | |
| AR127325A1 (es) | Métodos y composiciones para el tratamiento de la enfermedad renal poliquística | |
| JP2013537404A5 (https=) | ||
| JP2020525502A (ja) | 分子を経膜送達するための化合物及び方法 | |
| US10385090B2 (en) | Nucleotide derivative or salt thereof, nucleotide-derived 5′-phosphate ester or salt thereof, nucleotide-derived 3′-phosphoramidite compound or salt thereof, and polynucleotide | |
| CN102516339A (zh) | 嘧啶并嘧啶化合物及其核苷类似衍生物和制备方法及用途 | |
| US20240384269A1 (en) | Compositions containing nucleic acid nanoparticles and processes related to alteration of their physiochemical characteristics | |
| JP2018518167A5 (https=) | ||
| KR20190123351A (ko) | 개질된 올리고뉴클레오티드 및 이의 치료 용도 |